Home › Free Stock Grades › PRCT
PROCEPT BioRobotics Corporation (PRCT) Stock Grade
PRCT · Healthcare
C
Market Cap
$981.9M
P/E Ratio
—
Revenue Growth (YoY)
+37.2%
Net Margin
-31.0%
Return on Equity
—
Dividend Yield
None
About PROCEPT BioRobotics Corporation's fundamentals
PROCEPT BioRobotics is a medical device company with a market capitalization of $981.9 million that demonstrated strong revenue growth of 37.2% year-over-year, indicating expanding market adoption of its products. However, the company operates at a significant loss, with a net margin of -31.0%, meaning it spent $1.31 for every dollar of revenue generated in its latest fiscal year. The company does not pay a dividend and reported a net loss in its most recent annual statement, reflecting the typical financial profile of an early-stage medical device manufacturer investing heavily in growth and development.